Haruko Kunitomi

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Endometrial Cancer

Pluripotent Stem Cells

Anti Inflammatory Drugs

Top Venues

Journal of gynecologic oncology

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Takumi Okubo, Nicolas C Rivron, Mio Kabata, Hideki Masaki, Keiko Kishimoto, Katsunori Semi, May Nakajima-Koyama, Haruko Kunitomi, Belinda Kaswandy, Hideyuki Sato, Hiromitsu Nakauchi, Knut Woltjen, Mitinori Saitou, Erika Sasaki, Takuya Yamamoto, Yasuhiro Takashima
Publisher Correction: Hypoblast from human pluripotent stem cells regulates epiblast development. Nature (2024)
Takumi Okubo, Nicolas C Rivron, Mio Kabata, Hideki Masaki, Keiko Kishimoto, Katsunori Semi, May Nakajima-Koyama, Haruko Kunitomi, Belinda Kaswandy, Hideyuki Sato, Hiromitsu Nakauchi, Knut Woltjen, Mitinori Saitou, Erika Sasaki, Takuya Yamamoto, Yasuhiro Takashima
Hypoblast from human pluripotent stem cells regulates epiblast development. Nature (2023)
Haruko Kunitomi, Yusuke Kobayashi, Ren-Chin Wu, Takashi Takeda, Eiichiro Tominaga, Kouji Banno, Daisuke Aoki
LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer. Journal of gynecologic oncology 31 (2) (2019)
Nobuhiro Takahashi, Hiroyuki Nobusue, Takatsune Shimizu, Eiji Sugihara, Sayaka Yamaguchi-Iwai, Nobuyuki Onishi, Haruko Kunitomi, Tatsuo Kuroda, Hideyuki Saya
ROCK Inhibition Induces Terminal Adipocyte Differentiation and Suppresses Tumorigenesis in Chemoresistant Osteosarcoma Cells. Cancer research 79 (12) (2019)
Yusuke Kobayashi, Kouji Banno, Haruko Kunitomi, Eiichiro Tominaga, Daisuke Aoki
Current state and outlook for drug repositioning anticipated in the field of ovarian cancer. Journal of gynecologic oncology 30 (1) (2018)